Girish Aakalu
2019
In 2019, Girish Aakalu earned a total compensation of $798.1K as Chief Business Officer at Genocea Biosciences.
Compensation breakdown
Bonus | $150,000 |
---|---|
Non-Equity Incentive Plan | $146,300 |
Option Awards | $112,908 |
Salary | $385,000 |
Other | $3,850 |
Total | $798,058 |
Aakalu received $385K in salary, accounting for 48% of the total pay in 2019.
Aakalu also received $150K in bonus, $146.3K in non-equity incentive plan, $112.9K in option awards and $3.9K in other compensation.
Rankings
In 2019, Girish Aakalu's compensation ranked 10,226th out of 13,971 executives tracked by ExecPay. In other words, Aakalu earned more than 26.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,226 out of 13,971 | 27th |
Division Manufacturing | 4,140 out of 5,701 | 27th |
Major group Chemicals And Allied Products | 1,581 out of 2,200 | 28th |
Industry group Drugs | 1,354 out of 1,886 | 28th |
Industry Biological Products, Except Diagnostic Substances | 300 out of 389 | 23rd |
Source: SEC filing on April 20, 2020.
Aakalu's colleagues
We found two more compensation records of executives who worked with Girish Aakalu at Genocea Biosciences in 2019.